Manufacturable divisible core tablets: OSDrC technology and contract formulation development.
Introducing split-type nucleated tablets! Split-type nucleated tablets can also be manufactured in one step.
The "OSDrC" technology, with its variable double-structure pestle, allows for precise and flexible control of the inner core, enabling the production of higher quality core tablets than ever before, as well as the development of various new dosage forms. With this technology, it is now possible to manufacture split-type core tablets in one step, which was previously impossible. For example, the "OSDrC Split-type Enteric Tablet" is an enteric tablet that can be split. Since the inner core is always encapsulated by the outer layer, it can maintain the desired release control characteristics even when split. 【Features】 ■ Split-type core tablets can be manufactured in one step ■ The inner core is always encapsulated by the outer layer ■ The desired release control characteristics can be maintained * Data demonstrating that the outer layer function is maintained even when the tablet is split, thanks to OSDrC technology, can be viewed by downloading the PDF below. * For more details about OSDrC technology, please refer to the OSDrC main brochure or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（2）
Download All Catalogs
Company information
Sanwa Chemical Research Institute, as a member of the Suzuken Group focused on health creation, provides services aimed at improving the quality of life (QOL) for people who wish for better health, centered around its two main businesses: "pharmaceuticals" and "diagnostic drugs." In the "pharmaceuticals business," we are steadily building a track record with a focus on new drugs in the areas of diabetes and kidney/dialysis-related fields. In the "diagnostic drugs business," we are continuously developing and launching self-blood glucose meters, sensors, and diagnostic drugs for infectious diseases. Furthermore, by adding two more businesses— the "OSDrC (Osudrack) business" utilizing innovative formulation technology and the "contract manufacturing business" with advanced quality control systems— Sanwa Chemical Research Institute continues to evolve further.
